Cookies show us what works. Privacy
Cookies show us what works. Privacy
22 funds hold it · 1 straight earnings beat
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Aug 17, 2026
Period ending
Jul 31, 2026
Earnings per share
$0.09 expected
Estimates as of Nov 20, 2026
EPS expected
$0.06 to $0.16
Revenue expected
13 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Jul 31, 2026Reported Aug 17, 2026 | $0.13est. $0.09 | +$0.04beat | $843.0MSEC filing | +16.6%from $723.0M |
| Apr 30, 2026Reported Jun 3, 2026 | -$0.60est. -$0.22 | -$0.38miss | $837.0MAlpha Vantage | No year-ago quarter |
| Jan 23, 2026Reported Apr 17, 2026 | -$0.47est. $0.13 | -$0.60miss | $790.0MSEC filing | +15.0%from $687.0M |
| Jul 25, 2025Reported Sep 8, 2026 | Not on file | No estimate | $723.0MSEC filing | No year-ago quarter |
| Jan 24, 2025Reported Apr 17, 2026 | Not on file | No estimate | $687.0MSEC filing | No year-ago quarter |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $752.0M | $790.0M | $837.0M | $843.0M |
| Cost of what it sold | $324.0M | $428.0M | $357.0M | $378.0M |
| Gross profit | $428.0M | $362.0M | $480.0M | $465.0M |
| What it spent | ||||
| Research and development | $111.0M | $114.0M | $99.0M | $115.0M |
| Sales and admin | $318.0M | $309.0M | $299.0M | $312.0M |
| Other operating costs | $9.0M | $32.0M | — | — |
| Total operating expenses | $438.0M | $455.0M | $398.0M | $427.0M |
| What was left | ||||
| Operating profit | -$10.0M | -$93.0M | $82.0M | $38.0M |
| Profit before tax | -$12.0M | -$99.0M | -$90.0M | $4.0M |
| Tax | $19.0M | $12.0M | $93.0M | $4.0M |
| Net profit | -$27.0M | -$119.0M | -$183.0M | $0 |
| EBITDA | $29.0M | -$60.0M | $121.0M | $79.0M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
36 macro signals shaping MMED right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results